Copycat Drugs Are a Terrible Problem, Says Lilly CEO

Copycat Drugs Are a Terrible Problem, Says Lilly CEO

S
Smart Finance
3 Video Views·Apr 29, 2026

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that are transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks says counterfeit drugs are a "terrible problem right now," because consumers "don't really know the dangers" they pose. This interview was recorded on December 10 at the Economic Club of Washington DC.
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
/ @davidrubenstein

Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer

Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter: / business
Facebook: / bloombergbusiness
Instagram: / bloombergbusiness